CLEVER HANDELN

Richten Sie Börsennews.de als Startseite ein

Hier klicken

GluR4

Der börsennews.de Newsüberblick zum Thema "GluR4"

TR ONE-News: Addex to Present at the BIO Investor Forum in San Francisco

07:02 Uhr 24.10.2011

Addex to Present at the BIO Investor Forum in San Francisco Addex Pharmaceuticals / Addex to Present at the BIO Investor Forum in San Francisco . Verarbeitet und übermittelt durch Thomson Reuters ONE. Für den Inhalt der Mitteilung ist der Emittent verantwortlich. Geneva, Switzerland, … weiter lesen

Addex to Present at the BIO Investor Forum in San Francisco

07:01 Uhr 24.10.2011

Geneva, Switzerland, October 24, 2011- Addex Pharmaceuticals (SIX:ADXN), a leading biopharmaceutical company pioneering allosteric modulation-based drug discovery and development, announced today that Dr. Bharatt Chowrira, CEO of Addex, will provide an update on the Company at the BIO … weiter lesen

DJ Thomson Reuters ONE/Addex to Present at the BIO Investor Forum in San Francisco

05:01 Uhr 24.10.2011

Addex Pharmaceuticals / Addex to Present at the BIO Investor Forum in San Francisco . Est traité et transmis par Thomson Reuters ONE. L"émetteur est uniquement responsable du contenu de ce communiqué de presse. Geneva, Switzerland, October 24, 2011 - Addex … weiter lesen

DJ Thomson Reuters ONE/Addex to Present at the BIO Investor Forum in San Francisco

05:01 Uhr 24.10.2011

Addex Pharmaceuticals / Addex to Present at the BIO Investor Forum in San Francisco . Verarbeitet und übermittelt durch Thomson Reuters ONE. Für den Inhalt der Mitteilung ist der Emittent verantwortlich. Geneva, Switzerland, October 24, 2011 - Addex Pharmaceuticals … weiter lesen

DJ Thomson Reuters ONE/Addex to Present in NYC at the Newsmakers in the Biotech Industry conference hosted by BioCentury and Thomson Reuters

16:02 Uhr 19.10.2011

Addex Pharmaceuticals / Addex to Present in NYC at the Newsmakers in the Biotech Industry conference hosted by BioCentury and Thomson Reuters . Est traité et transmis par Thomson Reuters ONE. L"émetteur est uniquement responsable du contenu de ce communiqué de presse. … weiter lesen

DJ Thomson Reuters ONE/Addex to Present in NYC at the Newsmakers in the Biotech Industry conference hosted by BioCentury and Thomson Reuters

16:02 Uhr 19.10.2011

Addex Pharmaceuticals / Addex to Present in NYC at the Newsmakers in the Biotech Industry conference hosted by BioCentury and Thomson Reuters . Verarbeitet und übermittelt durch Thomson Reuters ONE. Für den Inhalt der Mitteilung ist der Emittent verantwortlich. Geneva, … weiter lesen

DJ Thomson Reuters ONE/Addex to Present Progress on Multiple Allosteric Modulator Programs for Neurodegenerative and other Neurological Disorders

16:02 Uhr 03.10.2011

Addex Pharmaceuticals / Addex to Present Progress on Multiple Allosteric Modulator Programs for Neurodegenerative and other Neurological Disorders . Est traité et transmis par Thomson Reuters ONE. L"émetteur est uniquement responsable du contenu de ce communiqué de … weiter lesen

DJ Thomson Reuters ONE/Addex to Present Progress on Multiple Allosteric Modulator Programs for Neurodegenerative and other Neurological Disorders

16:01 Uhr 03.10.2011

Addex Pharmaceuticals / Addex to Present Progress on Multiple Allosteric Modulator Programs for Neurodegenerative and other Neurological Disorders . Verarbeitet und übermittelt durch Thomson Reuters ONE. Für den Inhalt der Mitteilung ist der Emittent verantwortlich. Six … weiter lesen

Addex Regains Rights to Parkinson's Drug Candidates from Merck

18:06 Uhr 02.09.2011

Geneva, Switzerland, 2 September 2011- Addex Pharmaceuticals (SIX:ADXN), a leading biopharmaceutical company pioneering allosteric modulation-based drug discovery and development, announced today that it will regain all rights to its metabotropic glutamate receptor 4 (mGluR4) … weiter lesen

DJ Thomson Reuters ONE/Addex Regains Rights to Parkinson's Drug Candidates from Merck

16:06 Uhr 02.09.2011

Addex Pharmaceuticals / Addex Regains Rights to Parkinson's Drug Candidates from Merck . Est traité et transmis par Thomson Reuters ONE. L"émetteur est uniquement responsable du contenu de ce communiqué de presse. Geneva, … weiter lesen